User:Allie Pointer/Pointer Sandbox 1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 54: Line 54:
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<ref name=il-12>PMID: 24514955</ref>
<ref name=il-12>PMID: 24514955</ref>
<ref name=heterodimeric>PMID: 10899108</ref>
<ref name=heterodimeric>PMID: 10899108</ref>
<references/>
<ref>DOI: 10.2174/187152809787582507</ref>

Revision as of 19:23, 28 April 2020

Interleukin-12 Background

Caption for this structure

Drag the structure with the mouse to rotate

References

[1] [2] [3]

  1. ↑ Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014 May;63(5):419-35. doi: 10.1007/s00262-014-1523-1., Epub 2014 Feb 11. PMID:24514955 doi:https://dx.doi.org/10.1007/s00262-014-1523-1
  2. ↑ Yoon C, Johnston SC, Tang J, Stahl M, Tobin JF, Somers WS. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J. 2000 Jul 17;19(14):3530-41. PMID:10899108 doi:https://dx.doi.org/10.1093/emboj/19.14.3530
  3. ↑ Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009 Mar;8(1):40-52. doi:, 10.2174/187152809787582507. PMID:19275692 doi:https://dx.doi.org/10.2174/187152809787582507

Proteopedia Page Contributors and Editors (what is this?)

Allie Pointer